Leaders in Biobanking Congress

Today, biospecimen collections are used by multiple research groups for
varying research aims, from basic research through clinical trials. A
well-

managed biobank is a critical prerequisite for high-quality biological
research. The proper collection, processing, storage and tracking of
biospecimens

are critical components allowing researchers to better link molecular
and clinical information. Thus, by necessity, biobanking is both a
science and a

business. Cambridge Healthtech Institute’s Seventh International Leaders in Biobanking Congress: Maximizing Your Investment in Biospecimens addresses

both the business and science of
biobanking, bringing together biomedical and biopharmaceutical
researchers, regulators, biorepository managers and

practitioners to investigate the best strategies for effective use of
biospecimens within today’s cutting-edge biomedical research. More info